MCID: BLS005
MIFTS: 13

Blastema Predominant Kidney Wilms' Tumor

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Blastema Predominant Kidney Wilms' Tumor

MalaCards integrated aliases for Blastema Predominant Kidney Wilms' Tumor:

Name: Blastema Predominant Kidney Wilms' Tumor 12
Blastema Predominant Kidney Wilms' Tumour 12
Blastema Predominant Kidney Adenosarcoma 12
Blastema Predominant Renal Wilms Tumour 12
Blastema Predominant Renal Wilms Tumor 12
Blastema Predominant Wilms' Tumor 71

Classifications:



External Ids:

Disease Ontology 12 DOID:5182
NCIt 49 C9147
UMLS 71 C0279609

Summaries for Blastema Predominant Kidney Wilms' Tumor

MalaCards based summary : Blastema Predominant Kidney Wilms' Tumor, is also known as blastema predominant kidney wilms' tumour, and has symptoms including abdominal pain The drugs Vincristine and Dactinomycin have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Blastema Predominant Kidney Wilms' Tumor

Symptoms & Phenotypes for Blastema Predominant Kidney Wilms' Tumor

UMLS symptoms related to Blastema Predominant Kidney Wilms' Tumor:


abdominal pain

Drugs & Therapeutics for Blastema Predominant Kidney Wilms' Tumor

Drugs for Blastema Predominant Kidney Wilms' Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
2
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
3
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
4
Etoposide Approved Phase 3 33419-42-0 36462
5
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
6
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
7 Antibiotics, Antitubercular Phase 3
8 Immunologic Factors Phase 3
9 Etoposide phosphate Phase 3
10 Alkylating Agents Phase 3
11 Anti-Infective Agents Phase 3
12 Immunosuppressive Agents Phase 3
13 Anti-Bacterial Agents Phase 3
14
Liposomal doxorubicin Phase 3 31703
15 Tubulin Modulators Phase 3
16 Antirheumatic Agents Phase 3
17 Antimitotic Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nephroblastoma (Wilms Tumour) Clinical Trial And Study Unknown status NCT00047138 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate

Search NIH Clinical Center for Blastema Predominant Kidney Wilms' Tumor

Genetic Tests for Blastema Predominant Kidney Wilms' Tumor

Anatomical Context for Blastema Predominant Kidney Wilms' Tumor

MalaCards organs/tissues related to Blastema Predominant Kidney Wilms' Tumor:

40
Kidney

Publications for Blastema Predominant Kidney Wilms' Tumor

Articles related to Blastema Predominant Kidney Wilms' Tumor:

# Title Authors PMID Year
1
Primary primitive neuroectodermal tumor of the kidney: a case report. 61
16868682 2006
2
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. 61
11859203 2002
3
Adult Wilms' tumor. Intraoperative cytology and ancillary studies performed in a case as an adjunct to the histologic diagnosis. 61
1688679 1990

Variations for Blastema Predominant Kidney Wilms' Tumor

Expression for Blastema Predominant Kidney Wilms' Tumor

Search GEO for disease gene expression data for Blastema Predominant Kidney Wilms' Tumor.

Pathways for Blastema Predominant Kidney Wilms' Tumor

GO Terms for Blastema Predominant Kidney Wilms' Tumor

Sources for Blastema Predominant Kidney Wilms' Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....